Approval For Expansion of Subzone 61D; Merck Sharpe & Dohme Quimica De Puerto Rico, Inc. (Pharmaceutical Products); Arecibo, Puerto Rico, 62582 [E6-17968]

Download as PDF 62582 Federal Register / Vol. 71, No. 207 / Thursday, October 26, 2006 / Notices DEPARTMENT OF COMMERCE DEPARTMENT OF COMMERCE DEPARTMENT OF COMMERCE Foreign–Trade Zones Board Foreign-Trade Zones Board Foreign-Trade Zones Board [Order No. 1484] [Order No. 1485] [Order No. 1486] Approval for Expansion of Subzone 35B, Merck & Company, Inc., (Pharmaceutical Products), West Point, Pennsylvania Approval For Expansion of Subzone 61D; Merck Sharpe & Dohme Quimica De Puerto Rico, Inc. (Pharmaceutical Products); Arecibo, Puerto Rico Approval For Expansion of Subzone 61E; Merck Sharpe & Dohme Quimica De Puerto Rico, Inc. (Pharmaceutical Products); Barceloneta, Puerto Rico Pursuant to its authority under the Foreign– Trade Zones Act of June 18, 1934, as amended (19 U.S.C. 81a–81u), the Foreign– Trade Zones Board (the Board) adopts the following Order: Pursuant to its authority under the ForeignTrade Zones Act of June 18, 1934, as amended (19 U.S.C. 81a–81u), the ForeignTrade Zones Board (the Board) adopts the following Order: Pursuant to its authority under the ForeignTrade Zones Act of June 18, 1934, as amended (19 U.S.C. 81a–81u), the ForeignTrade Zones Board (the Board) adopts the following Order: WHEREAS, the Philadelphia Regional Port Authority, grantee of FTZ 35, has requested authority on behalf of Merck & Company, Inc. (Merck), to expand the subzone and scope of manufacturing authority in terms of capacity at Subzone 35B at the Merck pharmaceutical manufacturing plant in West Point, Pennsylvania (FTZ Docket 61–2005, filed 12/7/05); and, WHEREAS, notice inviting public comment has been given in the Federal Register (70 FR 74290, 12/15/05); WHEREAS, the Board adopts the findings and recommendations of the examiner’s report, and finds that the requirements of the FTZ Act and the Board’s regulations are satisfied, and that approval of the application is in the public interest; NOW, THEREFORE, the Board hereby approves the expansion of the subzone and the scope of authority under zone procedures in terms of capacity within Subzone 35B for the manufacture of pharmaceutical products at the Merck & Company, Inc., plant located in West Point, Pennsylvania, as described in the application and the Federal Register notice, subject to the FTZ Act and the Board’s regulations, including § 400.28. Signed at Washington, DC, this 20th day of October 2006. Whereas, the Puerto Rico Trade & Export Company, grantee of FTZ 61, has requested authority on behalf of Merck Sharpe & Dohme Quimica De Puerto Rico, Inc. (MSDQ), to expand the subzone and scope of manufacturing authority in terms of capacity at Subzone 61D at the MSDQ pharmaceutical manufacturing plant in Arecibo, Puerto Rico (FTZ Docket 62– 2005, filed 12/7/05); and, Whereas, notice inviting public comment has been given in the Federal Register (70 FR 74290, 12/15/05); Whereas, the Board adopts the findings and recommendations of the examiner’s report, and finds that the requirements of the FTZ Act and the Board’s regulations are satisfied, and that approval of the application is in the public interest; Now, therefore, the Board hereby approves the expansion of the subzone and the scope of authority under zone procedures in terms of capacity within Subzone 61D for the manufacture of pharmaceutical products at the Merck Sharpe & Dohme Quimica De Puerto Rico, Inc., plant located in Arecibo, Puerto Rico, as described in the application and the Federal Register notice, subject to the FTZ Act and the Board’s regulations, including Section 400.28. Whereas, the Puerto Rico Trade & Export Company, grantee of FTZ 61, has requested authority on behalf of Merck Sharpe & Dohme Quimica De Puerto Rico, Inc. (MSDQ), to expand the subzone and scope of manufacturing authority in terms of capacity at Subzone 61E at the MSDQ pharmaceutical manufacturing plant in Barceloneta, Puerto Rico (FTZ Docket 63–2005, filed 12/7/05); and, Whereas, notice inviting public comment has been given in the Federal Register (70 FR 74290, 12/15/05); Whereas, the Board adopts the findings and recommendations of the examiner’s report, and finds that the requirements of the FTZ Act and the Board’s regulations are satisfied, and that approval of the application is in the public interest; Now, therefore, the Board hereby approves the expansion of the subzone and the scope of authority under zone procedures in terms of capacity within Subzone 61E for the manufacture of pharmaceutical products at the Merck Sharpe & Dohme Quimica De Puerto Rico, Inc., plant located in Barceloneta, Puerto Rico, as described in the application and the Federal Register notice, subject to the FTZ Act and the Board’s regulations, including § 400.28. David M. Spooner, Assistant Secretary of Commerce For Import Administration, Alternate Chairman Foreign– Trade Zones Board. Attest: Pierre V. Duy, Acting Executive Secretary. [FR Doc. E6–17972 Filed 10–25–06; 8:45 am] ycherry on PROD1PC64 with NOTICES BILLING CODE 3510–DS–S Signed at Washington, DC, this 20th day of October 2006. David M. Spooner, Assistant Secretary of Commerce for Import Administration, Alternate Chairman, ForeignTrade Zones Board. Attest: Pierre V. Duy, Acting Executive Secretary. [FR Doc. E6–17968 Filed 10–25–06; 8:45 am] Signed at Washington, DC, this 20th day of October 2006. David M. Spooner, Assistant Secretary of Commerce for Import Administration, Alternate Chairman, ForeignTrade Zones Board. Attest: Pierre V. Duy, Acting Executive Secretary. [FR Doc. E6–17969 Filed 10–25–06; 8:45 am] BILLING CODE 3510–DS–P BILLING CODE 3510–DS–P VerDate Aug<31>2005 15:21 Oct 25, 2006 Jkt 211001 PO 00000 Frm 00002 Fmt 4703 Sfmt 4703 E:\FR\FM\26OCN1.SGM 26OCN1

Agencies

[Federal Register Volume 71, Number 207 (Thursday, October 26, 2006)]
[Notices]
[Page 62582]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-17968]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[Order No. 1485]


Approval For Expansion of Subzone 61D; Merck Sharpe & Dohme 
Quimica De Puerto Rico, Inc. (Pharmaceutical Products); Arecibo, Puerto 
Rico

    Pursuant to its authority under the Foreign-Trade Zones Act of 
June 18, 1934, as amended (19 U.S.C. 81a-81u), the Foreign-Trade 
Zones Board (the Board) adopts the following Order:

    Whereas, the Puerto Rico Trade & Export Company, grantee of FTZ 61, 
has requested authority on behalf of Merck Sharpe & Dohme Quimica De 
Puerto Rico, Inc. (MSDQ), to expand the subzone and scope of 
manufacturing authority in terms of capacity at Subzone 61D at the MSDQ 
pharmaceutical manufacturing plant in Arecibo, Puerto Rico (FTZ Docket 
62-2005, filed 12/7/05); and,
    Whereas, notice inviting public comment has been given in the 
Federal Register (70 FR 74290, 12/15/05);
    Whereas, the Board adopts the findings and recommendations of the 
examiner's report, and finds that the requirements of the FTZ Act and 
the Board's regulations are satisfied, and that approval of the 
application is in the public interest;
    Now, therefore, the Board hereby approves the expansion of the 
subzone and the scope of authority under zone procedures in terms of 
capacity within Subzone 61D for the manufacture of pharmaceutical 
products at the Merck Sharpe & Dohme Quimica De Puerto Rico, Inc., 
plant located in Arecibo, Puerto Rico, as described in the application 
and the Federal Register notice, subject to the FTZ Act and the Board's 
regulations, including Section 400.28.

    Signed at Washington, DC, this 20th day of October 2006.
David M. Spooner,
Assistant Secretary of Commerce for Import Administration, Alternate 
Chairman, Foreign-Trade Zones Board.
    Attest:
Pierre V. Duy,
Acting Executive Secretary.
 [FR Doc. E6-17968 Filed 10-25-06; 8:45 am]
BILLING CODE 3510-DS-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.